PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Reports Third Quarter 2021 Financial Results

03 Nov 2021 08:00:03 By Nasdaq GlobeNewswire

Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition

02 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021

27 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management

11 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL

08 Oct 2021 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®

04 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility

30 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries

21 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021

15 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

08 Sep 2021 08:00:04 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021

10 Aug 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference

04 Aug 2021 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

03 Aug 2021 08:00:03 By Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process

02 Aug 2021 08:00:01 By Nasdaq GlobeNewswire

New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty

29 Jul 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021

20 Jul 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

13 Jul 2021 08:00:03 By Nasdaq GlobeNewswire

Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America

22 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

08 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block

26 May 2021 08:00:01 By Nasdaq GlobeNewswire